Mutual Of America Capital Management LLC United Therapeutics Corp Transaction History

Mutual Of America Capital Management LLC

  • $9.12 Billion
  • Q4 2024

A detailed history of Mutual Of America Capital Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 23,583 shares of UTHR stock, worth $8.74 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
23,583
Previous 24,047 1.93%
Holding current value
$8.74 Million
Previous $8.62 Million 3.44%
% of portfolio
0.09%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
SELL
$348.66 - $410.0 $161,778 - $190,240
-464 Reduced 1.93%
23,583 $8.32 Million
Q3 2024

Nov 06, 2024
SELL
$311.04 - $363.55 $420,215 - $491,156
-1,351 Reduced 5.32%
24,047 $8.62 Million
Q2 2024

Aug 09, 2024
SELL
$228.26 - $319.04 $594,160 - $830,461
-2,603 Reduced 9.3%
25,398 $8.09 Million
Q1 2024

May 02, 2024
SELL
$210.76 - $249.51 $206,544 - $244,519
-980 Reduced 3.38%
28,001 $6.43 Million
Q4 2023

Jan 26, 2024
SELL
$214.88 - $256.94 $324,039 - $387,465
-1,508 Reduced 4.95%
28,981 $6.37 Million
Q3 2023

Nov 09, 2023
SELL
$211.82 - $248.24 $755,561 - $885,472
-3,567 Reduced 10.47%
30,489 $6.89 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $534,519 - $606,938
-2,605 Reduced 7.11%
34,056 $7.52 Million
Q1 2023

May 04, 2023
SELL
$212.99 - $276.17 $163,789 - $212,374
-769 Reduced 2.05%
36,661 $8.21 Million
Q4 2022

Feb 10, 2023
BUY
$205.95 - $280.43 $179,176 - $243,974
870 Added 2.38%
37,430 $10.4 Million
Q3 2022

Nov 08, 2022
SELL
$203.3 - $244.17 $267,949 - $321,816
-1,318 Reduced 3.48%
36,560 $7.66 Million
Q2 2022

Aug 10, 2022
SELL
$174.81 - $241.14 $557,119 - $768,513
-3,187 Reduced 7.76%
37,878 $8.93 Million
Q1 2022

May 02, 2022
BUY
$166.16 - $213.96 $131,598 - $169,456
792 Added 1.97%
41,065 $7.37 Million
Q4 2021

Feb 03, 2022
BUY
$184.32 - $216.08 $129,024 - $151,256
700 Added 1.77%
40,273 $8.7 Million
Q3 2021

Nov 10, 2021
BUY
$179.86 - $214.88 $15,108 - $18,049
84 Added 0.21%
39,573 $7.3 Million
Q2 2021

Aug 06, 2021
SELL
$170.47 - $211.93 $121,033 - $150,470
-710 Reduced 1.77%
39,489 $7.09 Million
Q1 2021

May 13, 2021
SELL
$153.94 - $174.85 $231,679 - $263,149
-1,505 Reduced 3.61%
40,199 $6.72 Million
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $29,134 - $43,411
286 Added 0.69%
41,704 $6.33 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $56,843 - $68,922
569 Added 1.39%
41,418 $4.18 Million
Q2 2020

Aug 06, 2020
BUY
$92.74 - $125.82 $2,782 - $3,774
30 Added 0.07%
40,849 $4.94 Million
Q1 2020

May 11, 2020
BUY
$79.39 - $115.35 $122,816 - $178,446
1,547 Added 3.94%
40,819 $3.87 Million
Q4 2019

Feb 11, 2020
BUY
$78.31 - $95.34 $14,878 - $18,114
190 Added 0.49%
39,272 $3.46 Million
Q3 2019

Nov 14, 2019
BUY
$74.85 - $85.99 $20,958 - $24,077
280 Added 0.72%
39,082 $3.12 Million
Q2 2019

Aug 12, 2019
BUY
$76.06 - $120.81 $30,347 - $48,203
399 Added 1.04%
38,802 $3.03 Million
Q1 2019

May 13, 2019
SELL
$107.15 - $126.84 $112,293 - $132,928
-1,048 Reduced 2.66%
38,403 $4.51 Million
Q4 2018

Feb 12, 2019
BUY
$101.4 - $128.73 $151,187 - $191,936
1,491 Added 3.93%
39,451 $4.3 Million
Q3 2018

Nov 13, 2018
SELL
$113.81 - $129.46 $48,596 - $55,279
-427 Reduced 1.11%
37,960 $4.85 Million
Q2 2018

Aug 09, 2018
BUY
$101.14 - $118.31 $184,074 - $215,324
1,820 Added 4.98%
38,387 $4.34 Million
Q1 2018

May 11, 2018
SELL
$107.21 - $151.94 $16,831 - $23,854
-157 Reduced 0.43%
36,567 $4.11 Million
Q4 2017

Jan 31, 2018
BUY
$118.58 - $151.28 $81,227 - $103,626
685 Added 1.9%
36,724 $5.43 Million
Q3 2017

Oct 18, 2017
BUY
$114.6 - $136.81 $4.13 Million - $4.93 Million
36,039
36,039 $4.22 Million

Others Institutions Holding UTHR

# of Institutions
719
Shares Held
60.7M
Call Options Held
181K
Put Options Held
158K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email